by Ekrem Duman | Aug 2, 2026 | Healthcare, Biotech & Life Sciences, Singapore Company Stories
⚡ TL;DRSingapore is ageing faster than almost any country in history, with the share of residents over sixty-five rising steeply through the 2030s. The healthcare, workforce and fiscal consequences are the single largest structural challenge facing the country,...
by Ekrem Duman | Aug 2, 2026 | Healthcare, Biotech & Life Sciences, Singapore Company Stories
⚡ TL;DRSingapore built a substantial medical tourism business serving patients from Indonesia, Malaysia, Vietnam, Myanmar and beyond, drawn by specialist expertise and clinical outcomes. Regional competition, rising costs and improving healthcare in source...
by Ekrem Duman | Aug 2, 2026 | Healthcare, Biotech & Life Sciences, Singapore Company Stories
⚡ TL;DRSingapore funds healthcare through a layered system combining compulsory medical savings accounts, universal catastrophic insurance, a safety net endowment for those who cannot pay, and heavily subsidised public hospital care with subsidies scaled by ward...
by Ekrem Duman | Aug 2, 2026 | Healthcare, Biotech & Life Sciences, Singapore Company Stories
⚡ TL;DRSingapore launched a biomedical sciences initiative in 2000, building the Biopolis research campus and recruiting international scientists to create a life sciences sector from almost nothing. Two decades later the manufacturing side is a clear success,...
by Ekrem Duman | Aug 2, 2026 | Healthcare, Biotech & Life Sciences, Singapore Company Stories
⚡ TL;DRParkway Holdings built Singapore’s leading private hospital network around Mount Elizabeth and Gleneagles, then became the object of a 2010 bidding war between an Indian hospital group and Malaysia’s sovereign fund. The Malaysian fund won, and...
